Stop with the substance prohibitions already. Just stop. The people haven't given you permission, as required in this Republic. Not since 18A, in fact -- and that very specific permission was eventually, wisely rescinded by the people because it was abysmally stupid, horrifically expensive in every aspect AND abjectly failed. Predictably so, actually. Most importantly, it was anti-liberty, EVEN WHEN EXPRESSLY LAWFULLY DELEGATED, however empirically foolishly. Pray, how do I make my instructions more clear to the ostensibly purpose-instituted guardians of my unalienable peaceful liberty?
SB624
Senate · 2026 sessionRepublicanSigned into lawRestrictions on hemp-derived products
AIProhibits certain hemp-derived products, directs liquor licensees to comply with the prohibition, amends the definition of hemp, and establishes the offenses of criminal adulteration and distribution of adulterated controlled substances.
(New Title) restricting access to certain hemp-derived products and establishing the offenses of criminal adulteration and distribution of adulterated controlled substances.
Status
Signed into law · July 9, 2026- ✓Introduced
- ✓Senate
- ✓House
- ✓Governor
- ✓Law
Division of testimony
77 submissionsApril 29, 2026 Re: Urging an amendment to SB 624 — restricting access to certain hemp-derived products Dear Chair Roy, Vice Chair Rhodes, Clerk Murray, and honorable members of the House Committee on Criminal Justice and Public Safety: I am Karen O’Keefe, the director of state policies at the non-profit Marijuana Policy Project. We share legislators’ concerns about the current state of intoxicating hemp in New Hampshire. High-dose intoxicating hemp products are being sold without age gating and with packaging that mimics commercial candies. That needs to be addressed to protect youth and public health. That said, SB 624 goes too far. It deprives mature Granite Staters of beneficial natural products that improve their wellbeing and that are being embraced by Pres. Trump and his Center for Medicare and Medicaid Innovation. While there are some bad actors in the intoxicating hemp space, there are also many companies producing full-spectrum CBD products to alleviate pain and other ailments and help with sleep. A cap of 0.4 milligrams of THC per container is too low. We urge you to amend SB 624 to avoid cutting off access to beneficial, full-spectrum CBD products that are currently federally legal and may well remain so. For context, as part of the “Big Beautiful Bill” that re-opened the federal government last fall, a rushed provision was included to cap total THC in hemp products at 0.4 milligrams of THC per container starting November 12, 2026. That cap may change soon. As part of his December 18, 2025, executive order on medical cannabis and cannabinoids, Pres. Trump directed staffers to work with Congress to revise it. On April 23, 2026, President Trump posted to Truth Social: "In December, I signed a very important Executive Order calling for Research and Innovation for Hemp-derived CBD — Something that has made a HUGE difference for so many people. In fact, ONE in FIVE adults used it in the past year, and many say it improved their chronic pain enormously. Our wonderful Dr. Mehmet Oz moved fast to follow the directive in the Executive Order, and launched a model for some Seniors earlier this month. But more must be done! I am calling on Congress to update the Law to ensure that Americans can continue to access the full-spectrum CBD products they have come to rely on, and that help them, while preserving Congress's intent to restrict the sale of products that pose Health risks. We must get this done RIGHT and FAST, especially for those who saw that CBD helps them. Plus, I am told it will also help our GREAT FARMERS, who we love, and will always be there for. Please get it done, and SOON. Thank you for your attention to this matter! President DONALD J. TRUMP" Last week, White House staff — consistent with Trump’s executive order — reportedly provided amendment language to Rep. Andy Barr (R-KY) to allow full-spectrum CBD products. Unfortunately, the text of those amendments is not publicly available. Also pursuant to the executive order, a Center for Medicare and Medicaid Innovation pilot program launched earlier this month allowing Accountable Care Organizations and cancer oncology practices to provide hemp-derived cannabinoid products to patients. It would be a shame if New Hampshire prohibited cancer patients and other residents from receiving access to those products. We urge you to amend SB 624 to: — Change the limit for adults to 5 or 10 mg of THC per container instead of 0.4 milligrams. It could have a lower per serving cap of between 0.4 mg - 1 mg. — Apply the THC cap only to non-topical products. There is no need to impose a lower cap than 0.3% THC (the current definition of hemp) on topical treatments for arthritis, eczema, burn scars, and other ailments. Alternatively, SB 624 could be amended to create an exception for federally legal hemp-derived cannabinoid products. Then, New Hampshire’s approach would mirror any changes that happen at the federal level. If SB 624 is not amended, starting January 1, 2027, tens of thousands of Granite Staters will be barred from accessing full-spectrum CBD products that are helping them — even if those products remain federally legal due to changes President Trump is advocating for. Thank you for your public service and consideration. Sincerely, Karen O’Keefe Director of State Policies Marijuana Policy Project 202-905-2012 Sources: * Pres. Trump's Executive Order: https://www.federalregister.gov/documents/2025/12/23/2025-23846/increasing-medical-marijuana-and-cannabidiol-research * Truth Social Post: https://truthsocial.com/@realDonaldTrump/posts/116456354024090916 * Article on White House lobbying to allow full-spectrum products: https://www.marijuanamoment.net/white-house-weighs-in-on-hemp-legislation-as-gop-lawmaker-pushes-accelerated-thc-product-ban/ * Information on the new Medicare pilot initiative allowing full-spectrum products: https://www.newswire.com/news/howard-kessler-salutes-president-trump-on-expanding-access-to-22756096
This common sense legislation would provide the same type of safeguards that are in place for alcohol for young people under 21 and safeguards for the sale of tobacco products to underage youth. Please support this bill.
THC, irregardless of source, is mind-altering and detectable on toxicology screening of urine. With increasing evidence that human brain function is not fully mature under the age of 21 years, it should be self evident THC in the immature brain combined with erratic behavior, possibly leading to drug screening and prosecution, is not good. Thank you.
As a nurse researcher working on substance use disorder treatment and education projects across NH, I support our NH legislative efforts to protect our children, teens and families from classifications and advertising of products that are dangerous & addictive. I ask that you to support the passage of this bill.
These drugs are very dangerous for our teens to be able to access. As a pediatrician I definitely support the ban.
We need stricter penalties for establishments that continue to sell hemp-derived products despite a state law that already bans the sale of these products. Please support this bill.
Mind-altering drugs should NOT be optional to anyone without fully matured brain function, that is, under 21 years of age. SB 624 is consistent with medical science and expert opinion. Thank you.
Dear Members of the House Environment and Agriculture Committee, I’m writing regarding SB 624. I want to be clear—I understand the concern this bill is trying to address. There are real issues with how hemp-derived THC products are being marketed, labeled, and accessed, especially by younger people. That part matters, and it should be taken seriously. But the direction this bill takes feels less like informed regulation and more like a step toward banning through overly strict limits. What many of us want is not prohibition—we want information. We want clear labeling that actually reflects total THC content. We want products that are tested, transparent, and honestly represented so consumers know exactly what they’re buying. We want education around these products so people can make informed decisions, not guess based on confusing or misleading packaging. When policy leans too far into restriction without building a strong framework for education and transparency, it risks pushing things underground instead of making them safer. New Hampshire has an opportunity here to lead with smart policy—policy that informs, protects, and respects personal responsibility. That means focusing on accurate labeling, age enforcement, and public education, rather than setting limits so low that they function as a ban. If this bill is going to move forward, I strongly urge you to amend it in a way that prioritizes information, transparency, and safety over prohibition. We don’t need less access—we need better understanding. Thank you for your time and consideration, Kim Lawrence Resident of New Hampshire
Companies sell THC products by labeling them "hemp-derived" instead of "cannabis," exploiting a technicality in federal law. Hemp-derived products are already banned in New Hampshire, but Senate Bill 624 prohibits the sale of any hemp-derived THC products to anyone under 21 and strengthens penalties for licensed establishments that continue to sell these products. Please support this bill so we can keep these products out of the hands of young people.
Addiction is already wide spread and does not need more companies creating and selling more addictive products, ESPECIALLY to minors.
THC and the other cannibinods like Delta 8 and 10 are way to strong for young kids. Lynn Collins owner of Southern NH Drug Testing
Position recorded without written comment.
Position recorded without written comment.
Position recorded without written comment.
Position recorded without written comment.
Position recorded without written comment.
Position recorded without written comment.
Position recorded without written comment.
Position recorded without written comment.
Position recorded without written comment.
Position recorded without written comment.
Position recorded without written comment.
Position recorded without written comment.
Position recorded without written comment.